Clinical Trial

Colorectal Resections in Patients With Retroperitoneal Sarcoma

Study acronym: COLOSARC-Q
Recruiting
View on ClinicalTrials.gov →
Summary
COLOSARC-Q is a multicenter study with the objective of providing an up-to-date assessment of colorectal resections and reconstruction techniques in the context of multivisceral resections for retroperitoneal sarcomas, as well as colorectal surgery-associated complications and their impact on patients' quality of life. In multivisceral resections involving the colon and rectum, the primary aim is to achieve complete resection and preserve organ function. However, multivisceral resections have a high risk of perioperative morbidity including anastomotic leakage. The proposed project aims to determine the number of primary anastomoses, their insufficiency rates, and the fraction of patients with primary and secondary stomas. In addition, the patients' quality of life after multivisceral sarcoma resection is to be recorded using standardized surveys. The analysis has the potential to facilitate intraoperative decision-making for colorectal resections in the context of multivisceral resections.
Protocol Amendment History 3 changes
notable Trial sites expanded: 13 -> 16 locations 2026-07-24
notable Primary completion pushed: 2026-03 -> 2026-06-29 2026-07-24
minor Completion pushed: 2026-03 -> 2026-11-05 2026-07-24
Trial Details
NCT Number NCT06943612
Lead Sponsor Heidelberg University
Conditions Sarcoma, Soft Tissue, Retroperitoneal Sarcoma
Enrollment 120 participants
Start Date 2025-01-27
Primary Completion 2026-06-29 (estimated)
Study Completion 2026-11-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-23